Feb 15, 2023 / 03:30AM GMT
Saurabh Paliwal - Biocon Limited - Head of IR
Good morning, everyone. I'm Saurabh Paliwal from Biocon's Investor Relations team, and I want to welcome everyone to Biocon's Q3 FY '23 Earnings Conference Call. (Operator Instructions)
Today, to discuss the company's business performance and outlook, we have Dr. Kiran Mazumdar Shaw, our Executive Chairperson; Mr. Siddharth Mittal, CEO and MD of Biocon Limited, along with other senior management personnel from business segments, including generics, biosimilars and research services.
As I move on, I want to highlight the safe harbor related to today's conference call. The comments made during the call may be forward-looking in nature based on management's current beliefs and expectations. It must be viewed in relation to the risks that our business faces, that could cause our future results, performance or achievements to differ significantly from what is expressed or implied by such forward-looking statements. After the end of the call, if you need any further information or clarifications, please do reach out to me.
Now I would
Q3 2023 Biocon Ltd Earnings Call Transcript
Mar 20, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers